NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Cefotaxime


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data on enzyme research published by N. Benachour and colleagues
2009 OCT 19 ... concluded: "These modifications may result in a change of the pI to 5.5 and hydrolyze cefotaxime and ceftazidime." Benachour and colleagues published the results of their ...
Subject: Enzyme Research
Price: $3.00
*
New data from P.C. Kohner et al illuminate research in Escherichia coli
2009 SEP 14 ... report. "A total of 264 isolates were subjected to cefazolin, ceftriaxone, cefotaxime, ceftazidime, cefepime, and aztreonam agar dilution MIC determination; ESBL screening ...
Subject: Escherichia coli
Price: $3.00
*
New drug resistance study findings have been reported by M. Rousseldelvallez and co-researchers
2009 OCT 19 ... to penicillin minimal inhibitory concentrations (MIC > 1mg/L), amoxicillin, and cefotaxime (MIC > 2mg/L) slightly decreased but remained low: 10.6%, 1.2%, and 0.2% in 2003. ...
Subject: Drug Resistance
Price: $3.00
*
New drug resistance study findings have been reported by researchers at University of Ljubljana
2009 AUG 31 ... "All isolates were resistant to amoxicillin with clavulanic acid, ampicillin, cefotaxime, ciprofloxacin, cloxacillin, cefotaxime with clavulanic ...
Subject: Drug Resistance
Price: $3.00
*
New drug resistance study findings recently were published by researchers at Wuhan University
2009 SEP 21 ... maculates. The MIC of imcroporin against MRSA was 50 mu g/ml, 8-fold lower than that of cefotaxime and 40-fold lower than that of penicillin. Imcroporin killed bacteria rapidly in vitro, ...
Subject: Drug Resistance
Price: $3.00
*
New life sciences study findings recently were published by J.M. Cuellarrodriguez and co-researchers
2009 NOV 24 ... RDT: Blood from each bottle was inoculated on Mueller-Hinton agar. Ceftazidime and cefotaxime disks with and without clavulanic acid were added and incubated at 35 degrees C +/- 2 ...
Subject: Life Sciences
Price: $3.00
*
New microbiology findings from Technical University of Munich published
2009 SEP 22 ... are aerotolerant but grow only under strictly anoxic conditions. They are sensitive to cefotaxime, clarithromycin, erythromycin, metronidazole, tetracycline, tobramycin and vancomycin. ...
Subject: Microbiology
Price: $3.00
*
New Results from Study for Monitoring Antimicrobial Resistance Trends (SMART) Show Rates of In Vitro Susceptibility of E. coli Isolates to Commonly Used Antibiotics
2009 NOV 16 ... 7.48% 5.6 - 9.9 97.43% 96.7-98.0 cefotaxime 7.14% 5.3-9.5 98.27% 97.7-98.7 ...
Subject: Urinary Tract Infection
Price: $3.00
*
Recent studies by J. Chander and co-authors add new data to cholera findings
2009 SEP 21 ... Majority of the isolates were resistant to furazolidone but sensitive to gentamicin and cefotaxime. Resistance pattern to amoxycillin was variable. Three isolates were found to be ...
Subject: Cholera
Price: $3.00
*
Recent studies from Pusan National University add new data to plant sciences
2009 AUG 11 ... (BAP), 0.1 mg/l naphthalene acetic acid, 40 mg/l kanamycin, and 300 mg/l cefotaxime." "After two passages in the selective regeneration medium, the ...
Subject: Plant Sciences
Price: $3.00
*
Research from University of Tehran, Medical Department provide new insights into life sciences
2009 NOV 16 ... "The MICs of imipenem, meropenem, piperacillin-tazobactam, cefotaxime, polymixin B and tigecycline against 80 isolates of Acintobacter baumanii from 6 ...
Subject: Life Sciences
Price: $3.00
*
Research in the area of pharmaceuticals reported from S.S.N. Ling and colleagues
2009 AUG 10 ... liposomal uptake. Folic acid was physically coupled to the surface of the liposomes and cefotaxime was used as the model drug." "In-vivo evaluation was carried out oil ...
Subject: Pharmaceuticals
Price: $3.00
*
Scientists at University of Pennsylvania publish research in Enterobacteriaceae
2009 OCT 12 ... tests for the confirmation of ESBL production reliably detect these isolates if both cefotaxime and ceftazidime are tested, but only about half would be classified as a possible CTX-M ...
Subject: Enterobacteriaceae
Price: $3.00
*
Studies from INSERM in the area of enzyme research published
2009 AUG 24 ... KAR was uncommonly more resistant to cefepime and cefpirome than to ceftazidime and cefotaxime. Cloning and expression of the beta-lactamase gene content of this isolate into ...
Subject: Enzyme Research
Price: $3.00
*
Studies from R. Singh and colleagues reveal new findings on drug resistance
2009 OCT 12 ... killing of biofilms and planktonic cells with five antibiotics (oxacillin, cefotaxime, amikacin, ciprofloxacin and vancomycin) was analysed by treating them with each ...
Subject: Drug Resistance
Price: $3.00
*
Studies from University Hospital describe new findings in life sciences
2009 NOV 23 ... only intermediately resistant strains were detected (0.4%). Intermediate resistance to cefotaxime occurred both in meningitis cases (1.7%) and non-meningitis cases (0.4%). ...
Subject: Life Sciences
Price: $3.00
*
Study data from Central Hospital, Department of Urology update understanding of Escherichia coli risk factors
2009 NOV 1 ... E. coli were determined. The drug susceptibilities of 170 isolates to levofloxacin and cefotaxime or cefpirome were 77% and 96%, respectively. Fluoroquinolone-resistant E. coli (FQREc) ...
Subject: Escherichia coli Risk Factors
Price: $3.00
*
Study data from D.W. Hilbert et al provide new insights into Escherichia coli therapy
2009 NOV 23 ... ciprofloxacin (CIP), 2.5% for nitrofurantoin (F/M), 0.5% for ceftazidime (CAZ), 0.5% for cefotaxime (CTX), and 0% for fosfomycin (FOS). SXT non-susceptibility was associated with ...
Subject: Escherichia coli Therapy
Price: $3.00
*
Study data from P. Ruiz et al provide new insights into liver transplant
2009 OCT 12 ... Our posttransplant infection prophylactic protocol consisted of ampicillin and cefotaxime for 48 hours. Cultures were positive in 59 patients (98.4%). Seventy-five percent of the ...
Subject: Liver Transplant
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login